Edward Neilan | Chief Medical and Scientific Officer
National Organization for Rare Disorders (NORD)

Edward Neilan, Chief Medical and Scientific Officer, National Organization for Rare Disorders (NORD)

Appearances:



World Orphan Drug Congress USA 2022 - Day 1 @ 09:35

Keynote Panel: Advancing cell and gene therapies for rare diseases: What challenges face developers in pre-commercialization and how can all stakeholders work to get therapies to rare patients faster?

Moderator: Izaskun Elorza, Senior Medical Director,, Parexel
Janet Lynch Lambert, Chief Executive Officer, Alliance for Regenerative Medicine
Samarth Kulkarni, Chief Executive Officer, CRISPR Therapeutics
Edward Neilan, Chief Medical and Scientific Officer, National Organization for Rare Disorders (NORD)
Peter Marks, Director, Center For Biologics Evaluation And Research (CBER), U.S. Food and Drug Administration
Paolo Martini, Chief Scientific Officer, Rare Diseases, Moderna Therapeutics
last published: 29/Jun/22 01:45 GMT

back to speakers

Get Involved At World Orphan Drug Congress USA

 

To Sponsor Or Exhibit

 
 

Justin Franks
justin.franks@terrapinn.com
t/ +1 914 819 3506

 

 

 

To Speak

 
 

Claire Murphy
claire.murphy@terrapinn.com
t/ +1 646 619 1784

 

 

 

Marketing & Press Opportunities

 
 

Taylor Post 
taylor.post@terrapinn.com
t/ +1 646 619 1785